Latent, a San Franisco, CA-based clinical-AI company accelerating access to life-saving medications, has raised $80 million in Series A funding.
Investors
The round was co-led by Spark Capital and Transformation Capital, with participation from Conviction, McKesson Ventures, General Catalyst, and Y Combinator.
Latent Use of Funds
The company will use the funding to expand its health system footprint, enhance its clinical AI platform, strengthen integrations across healthcare stakeholders, and scale its team.
About Latent
Latent is a company that provides an AI platform for medication access. The company is building a clinical reasoning engine designed to bridge the gap between diagnosis and treatment in healthcare systems. Its platform automates complex clinical knowledge work by analyzing patient data, interpreting treatment criteria, and coordinating workflows across providers, payers, and pharmacies. Latent serves over 45 of the nation's leading health systems, including Yale New Haven Health, Ochsner Health, MetroHealth, UCI, Vanderbilt Health, Mount Sinai Health System, Henry Ford Health System, UCSF Health, and UCLA Health.
Funding Details
Company: Latent
Raised: $80.0M
Round: Series A
Funding Date: March 2026
Lead Investor: Spark Capital, Transformation Capital
Additional Investors: Conviction, McKesson Ventures, General Catalyst, Y Combinator
Company Website: https://latenthealth.com/
Software Category: Clinical AI/ Healthcare Workflow Automation
Source: https://latenthealth.com/press/latent-emerges-as-clinical-ai-leader-raising-80m-to-close-the-gap-between-diagnosis-and-treatment